...
首页> 外文期刊>BMC Infectious Diseases >Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China
【24h】

Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China

机译:中国耐多药结核病患者痰培养转化时间及治疗结果的影响因素

获取原文
           

摘要

Few prospective cohort studies, none in China, have investigated the relationship between treatment outcomes of multidrug-resistant tuberculosis (MDR-TB) patients and sputum culture conversion. Factors affecting the time of the culture conversion throughout the whole course of the treatment have rarely been investigated. This study was performed in four cities in Jiangsu province, China. MDR-TB patients were consecutively enrolled between December 2011 and March 2014. Rates of sputum culture conversion were calculated and Cox proportional-hazards model was performed. Factors contributing to sputum culture conversion were investigated. In all, 139 MDR-TB patients with treatment outcomes were enrolled. Median time to culture conversion among those who converted was 91.5?days (interquartile range, 34.0–110.8?days). After multivariable analysis, smoking (HR?=?0.44; 95% CI: 0.23–0.83), drinking (HR?=?0.41; 95% CI: 0.21–0.81), ofloxacin resistance (HR?=?0.43; 95% CI: 0.24–0.76) and sputum smear grade?>?1 (HR?=?0.51; 95% CI: 0.31–0.83) were less likely to have culture conversion. MDR-TB patients who smoke, drink, have ofloxacin resistance, or a high smear grade are less likely to respond to treatment and should be meticulously followed up.
机译:很少有前瞻性队列研究在中国进行,没有研究耐多药结核病(MDR-TB)患者治疗结果与痰培养转化之间的关系。很少研究影响整个治疗过程中培养物转化时间的因素。这项研究是在中国江苏省的四个城市进行的。在2011年12月至2014年3月期间连续招募了耐多药结核病患者。计算了痰培养的转化率,并进行了Cox比例风险模型。调查了影响痰培养转化的因素。总共招募了139名耐多药结核病患者。转化者中,转化成文化的中位数时间为91.5天(四分位间距为34.0-110.8天)。经过多变量分析后,吸烟(HR≥0.44; 95%CI:0.23-0.83),饮酒(HR≥0.41; 95%CI:0.21-0.81),氧氟沙星耐药性(HR≥0.43; 95%CI) :0.24-0.76)和痰涂片等级≥1(HR≤0.51; 95%CI:0.31-0.83)发生培养转化的可能性较小。吸烟,饮酒,对氧氟沙星耐药或涂片等级高的耐多药结核病患者对治疗的反应较小,应进行认真的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号